It is believed that the over-expression of VIM, which is related to poor prognosis in breast cancer patients presenting with metastasis potential [55,56], results in a more invasive capacity of breast cancer cells in vitro and in vivo [21,57,58]. This evidence concerns the gene VIM and breast cancer.